- Home
- ACET vs UONE Comparison
ACET vs UONE Comparison
Compare ACET & UONE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ACET
- UONE
- Stock Information
- Founded
- ACET 1947
- UONE 1980
- Country
- ACET United States
- UONE United States
- Employees
- ACET N/A
- UONE N/A
- Industry
- ACET Biotechnology: Pharmaceutical Preparations
- UONE Broadcasting
- Sector
- ACET Health Care
- UONE Consumer Discretionary
- Exchange
- ACET Nasdaq
- UONE Nasdaq
- Market Cap
- ACET 70.3M
- UONE 64.4M
- IPO Year
- ACET N/A
- UONE N/A
- Fundamental
- Price
- ACET $0.67
- UONE $1.39
- Analyst Decision
- ACET Buy
- UONE
- Analyst Count
- ACET 6
- UONE 0
- Target Price
- ACET $6.00
- UONE N/A
- AVG Volume (30 Days)
- ACET 312.0K
- UONE 19.4K
- Earning Date
- ACET 03-06-2025
- UONE 03-27-2025
- Dividend Yield
- ACET N/A
- UONE N/A
- EPS Growth
- ACET N/A
- UONE N/A
- EPS
- ACET N/A
- UONE N/A
- Revenue
- ACET N/A
- UONE $449,674,000.00
- Revenue This Year
- ACET N/A
- UONE N/A
- Revenue Next Year
- ACET N/A
- UONE N/A
- P/E Ratio
- ACET N/A
- UONE N/A
- Revenue Growth
- ACET N/A
- UONE N/A
- 52 Week Low
- ACET $0.67
- UONE $1.23
- 52 Week High
- ACET $2.40
- UONE $3.33
- Technical
- Relative Strength Index (RSI)
- ACET 32.94
- UONE 46.38
- Support Level
- ACET $0.74
- UONE $1.36
- Resistance Level
- ACET $0.91
- UONE $1.50
- Average True Range (ATR)
- ACET 0.06
- UONE 0.08
- MACD
- ACET -0.01
- UONE -0.00
- Stochastic Oscillator
- ACET 0.36
- UONE 17.65
About ACET Adicet Bio Inc.
Adicet Bio Inc is a clinical-stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for cancer and other diseases. Its product candidate, ADI-001, a first-in-class allogeneic gamma delta T cell therapy expressing a CAR targeting CD20, is being developed for the potential treatment of autoimmune diseases and relapsed or refractory aggressive B cell non-Hodgkin's lymphoma. Their pipeline also includes its preclinical candidate, ADI-270, an armored gamma delta CAR T cell product candidate targeting renal cell carcinoma, with potential for other CD70+ solid tumor and hematological malignancies indications.
About UONE Urban One Inc.
Urban One Inc is an urban oriented, multi-media company. Its business is radio broadcasting franchise that is the radio broadcasting operation that targets African-American and urban listeners. It operates through the following segments: Radio Broadcasting, Reach Media, Digital, and Cable Television. The Radio Broadcasting segment includes all the broadcasting related operations. The Reach Media segment consists of the Tom Joyner Morning Show and its related activities. The Digital segment focuses on its online business, including the operations of Interactive One. The Cable Television segment deals with TV One's operations.